Dr. Dinesh Kumar Dhanwal

Dr. Dinesh Kumar Dhanwal head of department up the department of Endocrinology, Diabetology, and Metabolic Disorders at NMC Specialty Hospital, Abu Dhabi. Widely regarded as one of the best endocrinologists in Abu Dhabi, Dr. Dinesh brings decades of experience in treating complex endocrine disorders. He is also a trusted diabetes specialist Abu Dhabi, offering comprehensive care for patients managing Type 1, Type 2, and gestational diabetes. His expertise as a thyroid doctor Abu Dhabi has helped many patients successfully manage thyroid conditions. In addition, he is a renowned hormone specialist Abu Dhabi, skilled in addressing a wide range of hormonal imbalances. Patients seeking a thyroid disorder specialist Abu Dhabi consistently rely on his evidence-based and personalized approach to care.

Clinical Expertise

He was on deputation to Zulekha Hospital as Consultant Endocrinologist from 2004–2006 and then went back to India where he was Director of the Department of Endocrinology at Maulana Azad Medical College. This was his most recent stint before joining NMC Specialty Hospital in Abu Dhabi in August 2014.

Professional Membership

He has been given awards by various Indian and international organizations that include, amongst others, the Japanese Society of Nuclear Medicine, APPES (Cairns, Australia), Commonwealth Commission (UK), Delhi State Doctors Award, Bhagirathi Samman, AV Gandhi Award for Excellence in Endocrinology (Bangalore).

Fellow of Americal Association of Clinical Endocrinologists. I received this fellowship in 2018 in LA, USA.

Publication and Research

Dr. Dinesh has published papers in various prestigious peer-reviewed international journals and has been a visiting professor at Yerevan State Medical University and a Commonwealth Fellow at the University of Southampton. He has held positions of Editor-in-Chief of the Journal of Advanced Medical Research (JoAMR), Editor of Medical Progress (Indian Edition), Editor of Scientific Proceedings Medicine Update 2006 and 2010, Reviewer for JCEM, EDM, BMJ case reports and also contributed to the Editorial Board of Indian Journal of Endocrinology and Metabolism.

Dr. Dinesh has also led and participated in over 10 clinical trials and has written over 50 research papers.

Presently in UAE involved in phase 3 and 4 clinical trials including on GLP1/GIPR1 such as semaglutide (Ozempic) and Tirzepatide (Mounjaro).